These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16410746

  • 21. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
    Zheng C, Sköld MK, Li J, Nennesmo I, Fadeel B, Henter JI.
    Biochem Biophys Res Commun; 2007 Nov 30; 363(4):989-93. PubMed ID: 17923114
    [Abstract] [Full Text] [Related]

  • 22. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.
    Glas M, Popp B, Angele B, Koedel U, Chahli C, Schmalix WA, Anneser JM, Pfister HW, Lorenzl S.
    Exp Neurol; 2007 Oct 30; 207(2):350-6. PubMed ID: 17716658
    [Abstract] [Full Text] [Related]

  • 23. Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine.
    Rei N, Valente CA, Vaz SH, Farinha-Ferreira M, Ribeiro JA, Sebastião AM.
    PLoS One; 2022 Oct 30; 17(12):e0272104. PubMed ID: 36516126
    [Abstract] [Full Text] [Related]

  • 24. Gene and protein therapies utilizing VEGF for ALS.
    Keifer OP, O'Connor DM, Boulis NM.
    Pharmacol Ther; 2014 Mar 30; 141(3):261-71. PubMed ID: 24177067
    [Abstract] [Full Text] [Related]

  • 25. Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System.
    Silva-Hucha S, Pastor AM, Morcuende S.
    Int J Mol Sci; 2021 Jan 15; 22(2):. PubMed ID: 33467517
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice.
    Chen Y, Guan Y, Zhang Z, Liu H, Wang S, Yu L, Wu X, Wang X.
    Neurol Res; 2012 May 15; 34(4):390-9. PubMed ID: 22643084
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
    Bogaert E, Van Damme P, Van Den Bosch L, Robberecht W.
    Muscle Nerve; 2006 Oct 15; 34(4):391-405. PubMed ID: 16856151
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Single chain precursor prohaptoglobin promotes angiogenesis by upregulating expression of vascular endothelial growth factor (VEGF) and VEGF receptor2.
    Oh MK, Park HJ, Lee JH, Bae HM, Kim IS.
    FEBS Lett; 2015 Apr 13; 589(9):1009-17. PubMed ID: 25775978
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas LJ, Mongan NP, Persson JL.
    Anticancer Res; 2013 Jun 13; 33(6):2381-90. PubMed ID: 23749886
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.